Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 47

Sort by

Sort Order Select

Journal Articles

IDH Mutations Identify a Subgroup of NPM1 Patients with a More Favorable Prognosis. a Retrospective Multicenter Study of the Filo Group

Sylvain Garciaz, Marie Anne Hospital, Colombe Saillard, MD, Yosr Hicheri, Evelyne D'Incan, Jerome Rey, Catherine Lacombe, Arnaud Pigneux, MD PhD, Marie-Christine Béné, PharmSciD, PhD, Christian Recher, MD PhD, Marie-Joelle Mozziconacci, Norbert Vey, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-141229

Published: 2020

Journal Articles

Comprehensive mutational profiling of core binding factor acute myeloid leukemia

Blood (2016) 127 (20): 2451–2459.

https://doi.org/10.1182/blood-2015-12-688705

Published: 2016

Includes: Supplemental data

Journal Articles

Deep Proteomic Analysis of Human Erythropoiesis

Sarah Ducamp, PhD, Emilie-Fleur Gautier, PhD, Marjorie Leduc, Virginie Salnot, Michael Dussiot, PhD, François Guillonneau, Marie-Catherine Giarratana, Luc Douay, MD PhD, Catherine Lacombe, MDPhD, Frederique Verdier, PhD, Yael Zermati, PhD, Patrick Mayeux, PhD

Blood (2015) 126 (23): 938.

https://doi.org/10.1182/blood.V126.23.938.938

Published: 2015

Journal Articles

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Blood (2015) 126 (23): 3736.

https://doi.org/10.1182/blood.V126.23.3736.3736

Published: 2015

Journal Articles

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition

Blood (2015) 126 (11): 1346–1356.

https://doi.org/10.1182/blood-2015-01-621870

Published: 2015

Includes: Supplemental data

Journal Articles

Co-Activation of AMPK and mTORC1 Is Synthetically Lethal in Acute Myeloid Leukemia

Blood (2014) 124 (21): 616.

https://doi.org/10.1182/blood.V124.21.616.616

Published: 2014

Journal Articles

PIM2 Pro-Survival Functions Are Mediated By RSK2 in AML

Marie-Anne Hospital, MD, Arnaud Jacquel, PhD, Alexa Green, Mireille Lambert, PhD, Patrick Auberger, PhD, Catherine Lacombe, Olivier Hermine, MD PhD, Ivan C Moura, PhD, Patrick Mayeux, PhD, Didier Bouscary, MD, Jerome Tamburini, MD PhD

Blood (2014) 124 (21): 912.

https://doi.org/10.1182/blood.V124.21.912.912

Published: 2014

Journal Articles

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/ RUNX1-RUNX1T1 chromosomal translocations

Jean-Baptiste Micol, Nicolas Duployez, Nicolas Boissel, Arnaud Petit, Sandrine Geffroy, Olivier Nibourel, Catherine Lacombe, Helene Lapillonne, Pascaline Etancelin, Martin Figeac, Aline Renneville, Sylvie Castaigne, Guy Leverger, Norbert Ifrah, Hervé Dombret, Claude Preudhomme, Omar Abdel-Wahab, Eric Jourdan

Blood (2014) 124 (9): 1445–1449.

https://doi.org/10.1182/blood-2014-04-571018

Published: 2014

Includes: Supplemental data

Journal Articles

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

Blood (2013) 122 (20): 3521–3532.

https://doi.org/10.1182/blood-2013-03-493163

Published: 2013

Includes: Supplemental data

Journal Articles

Epigenetic Down-Regulation of NFkB-Mediated FAS Gene Transcription During Progression of Myelodysplastic Syndromes

Sandrine Ettou, Catherine Humbrech, Blandine Benet, Katy Billot, Virginie Mariot, Olivier Kosmider, MD, PhD, Catherine Lacombe, Patrick Mayeux, Eric Solary, Michaela Fontenay, MD, PhD

Blood (2012) 120 (21): 3503.

https://doi.org/10.1182/blood.V120.21.3503.3503

Published: 2012

Journal Articles

The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells

Marie-Anne Hospital, Alexa S. Green, Catherine Lacombe, Patrick Mayeux, Didier Bouscary, Jerome Tamburini

Blood (2012) 119 (7): 1791–1792.

https://doi.org/10.1182/blood-2011-11-393066

Published: 2012

Journal Articles

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

Blood (2012) 119 (6): 1532–1542.

https://doi.org/10.1182/blood-2011-03-343475

Published: 2012

Includes: Supplemental data

Journal Articles

IDH1/2, TET2 and DNMT3A Mutations Are Not Mutually Exclusive in Secondary Acute Myeloid Leukemias,

Olivier Kosmider, Olivier LaRochelle, Marie-Magdelaine Coude, Veronique Mansat-De Mas, Eric Delabesse, Pascale Cornillet-Lefebvre, Odile Blanchet, Christian Recher, Alain Delmer, MD, Sophie Raynaud, Catherine Lacombe, Olivier Bernard, Norbert Ifrah, Francois Dreyfus, Michaela Fontenay

Blood (2011) 118 (21): 3556.

https://doi.org/10.1182/blood.V118.21.3556.3556

Published: 2011

Journal Articles

Addition of Gemtuzumab Ozogamycin to Chemotherapy Improves Event-Free Survival but Not Overall Survival of AML Patients with Intermediate Cytogenetics Not Eligible for Allogeneic Transplantation. Results of the GOELAMS AML 2006 IR Study

Blood (2011) 118 (21): 79.

https://doi.org/10.1182/blood.V118.21.79.79

Published: 2011

Journal Articles

Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis

Hana Forejtnikovà, Maud Vieillevoye, Yael Zermati, Mireille Lambert, Rosa Maria Pellegrino, Soizic Guihard, Muriel Gaudry, Clara Camaschella, Catherine Lacombe, Antonella Roetto, Patrick Mayeux, Frédérique Verdier

Blood (2010) 116 (24): 5357–5367.

https://doi.org/10.1182/blood-2010-04-281360

Published: 2010

Includes: Supplemental data

Journal Articles

Prognostic Impact of the Amount of CD34+ CD38- CD123+ Cells at Diagnosis In Acute Myeloid Leukemia: a Study From the GOELAMS

François Vergez, Alexa Green, Jérôme Tamburini, Nathalie Gallay, Murielle Roussel, Baptiste Gaillard, Aymeric Neyret, Melanie Pannetier, Nicolas Chapuis, Norbert Ifrah, Francois Dreyfus, Cécile Demur, Catherine Lacombe, Patrick Mayeux, Didier Bouscary, Stéphane Manenti, Christian Récher, MD, Valérie Bardet

Blood (2010) 116 (21): 951.

https://doi.org/10.1182/blood.V116.21.951.951

Published: 2010

Journal Articles

TET2 Mutations in Secondary Acute Myeloid Leukemias: A French Retrospective Study

Olivier Kosmider, Véronique De Mas, Eric Delabesse, Pascale Cornillet-lefevre, Odile Blanchet, Christian Récher, Sophie Raynaud, Catherine Lacombe, Olivier Bernard, Norbert Ifrah, Francois Dreyfus, Michaëla Fontenay on behalf of the GOELAMS

Blood (2010) 116 (21): 176.

https://doi.org/10.1182/blood.V116.21.176.176

Published: 2010

Journal Articles

FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes

Sandrine Ettou, Catherine Humbrecht, Blandine Benet, Olivier Kosmider, Nathalie Droin, PhD, Odile Beyne-Rauzy, Bruno Quesnel, Catherine Lacombe, Dreyfus Francois, Patrick Mayeux, Eric Solary, Michaëla Fontenay

Blood (2010) 116 (21): 232.

https://doi.org/10.1182/blood.V116.21.232.232

Published: 2010

Journal Articles

IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia

Nicolas Chapuis, Sophie Park, Laurent Leotoing, Jerome Tamburini, Frederique Verdier, Valerie Bardet, Alexa S. Green, Lise Willems, Fabrice Agou, Norbert Ifrah, François Dreyfus, Georges Bismuth, Veronique Baud, Catherine Lacombe, Patrick Mayeux, Didier Bouscary

Blood (2010) 116 (20): 4240–4250.

https://doi.org/10.1182/blood-2009-12-260711

Published: 2010

Includes: Supplemental data

Journal Articles

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

Alexa S. Green, Nicolas Chapuis, Thiago Trovati Maciel, Lise Willems, Mireille Lambert, Christophe Arnoult, Olivier Boyer, Valerie Bardet, Sophie Park, Marc Foretz, Benoit Viollet, Norbert Ifrah, François Dreyfus, Olivier Hermine, Ivan Cruz Moura, Catherine Lacombe, Patrick Mayeux, Didier Bouscary, Jerome Tamburini

Blood (2010) 116 (20): 4262–4273.

https://doi.org/10.1182/blood-2010-02-269837

Published: 2010

Includes: Supplemental data

NARROW

IDH Mutations Identify a Subgroup of NPM1 Patients with a More Favorable Prognosis. a Retrospective Multicenter Study of the Filo Group

Comprehensive mutational profiling of core binding factor acute myeloid leukemia

Deep Proteomic Analysis of Human Erythropoiesis

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition

Co-Activation of AMPK and mTORC1 Is Synthetically Lethal in Acute Myeloid Leukemia

PIM2 Pro-Survival Functions Are Mediated By RSK2 in AML

Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/ RUNX1-RUNX1T1 chromosomal translocations

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

Epigenetic Down-Regulation of NFkB-Mediated FAS Gene Transcription During Progression of Myelodysplastic Syndromes

The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

IDH1/2, TET2 and DNMT3A Mutations Are Not Mutually Exclusive in Secondary Acute Myeloid Leukemias,

Addition of Gemtuzumab Ozogamycin to Chemotherapy Improves Event-Free Survival but Not Overall Survival of AML Patients with Intermediate Cytogenetics Not Eligible for Allogeneic Transplantation. Results of the GOELAMS AML 2006 IR Study

Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis

Prognostic Impact of the Amount of CD34+ CD38- CD123+ Cells at Diagnosis In Acute Myeloid Leukemia: a Study From the GOELAMS

TET2 Mutations in Secondary Acute Myeloid Leukemias: A French Retrospective Study

FAS Gene Expression Is Epigenetically Regulated and Predicts the Responsiveness to Azacitidine In High-Risk Myelodysplastic Syndromes

IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia

The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only